KalVista Pharmaceuticals Inc (KALV)
9.33
+0.37
(+4.13%)
USD |
NASDAQ |
Nov 21, 16:00
9.33
0.00 (0.00%)
After-Hours: 17:45
KalVista Pharmaceuticals Market Cap: 459.18M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 440.97M |
| November 19, 2024 | 445.40M |
| November 18, 2024 | 457.70M |
| November 15, 2024 | 467.06M |
| November 14, 2024 | 482.31M |
| November 13, 2024 | 514.30M |
| November 12, 2024 | 525.13M |
| November 11, 2024 | 545.80M |
| November 08, 2024 | 561.55M |
| November 07, 2024 | 550.23M |
| November 06, 2024 | 561.55M |
| November 05, 2024 | 553.67M |
| November 04, 2024 | 502.60M |
| November 01, 2024 | 458.52M |
| October 31, 2024 | 443.82M |
| October 30, 2024 | 484.01M |
| October 29, 2024 | 509.51M |
| October 28, 2024 | 522.48M |
| October 25, 2024 | 504.76M |
| October 24, 2024 | 521.61M |
| October 23, 2024 | 519.02M |
| October 22, 2024 | 533.71M |
| October 21, 2024 | 532.42M |
| October 18, 2024 | 540.19M |
| October 17, 2024 | 522.48M |
| Date | Value |
|---|---|
| October 16, 2024 | 532.85M |
| October 15, 2024 | 517.72M |
| October 14, 2024 | 506.49M |
| October 11, 2024 | 502.60M |
| October 10, 2024 | 474.94M |
| October 09, 2024 | 485.74M |
| October 08, 2024 | 484.45M |
| October 07, 2024 | 487.47M |
| October 04, 2024 | 490.93M |
| October 03, 2024 | 498.71M |
| October 02, 2024 | 511.67M |
| October 01, 2024 | 492.22M |
| September 30, 2024 | 500.44M |
| September 27, 2024 | 533.28M |
| September 26, 2024 | 432.16M |
| September 25, 2024 | 408.82M |
| September 24, 2024 | 417.03M |
| September 23, 2024 | 422.65M |
| September 20, 2024 | 453.33M |
| September 19, 2024 | 475.37M |
| September 18, 2024 | 461.97M |
| September 17, 2024 | 456.79M |
| September 16, 2024 | 465.43M |
| September 13, 2024 | 481.42M |
| September 12, 2024 | 452.03M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
103.33M
Minimum
Oct 19 2022
1.019B
Maximum
Feb 16 2021
367.39M
Average
333.41M
Median
Nov 25 2020
Market Cap Benchmarks
| Nuwellis Inc | 5.380M |
| Perspective Therapeutics Inc | 202.09M |
| Electromed Inc | 235.72M |
| Xtant Medical Holdings Inc | 57.09M |
| Myomo Inc | 144.58M |
Market Cap Related Metrics
| PS Ratio | 29.22 |
| PEG Ratio | -0.3487 |
| Price to Book Value | 2.657 |
| Price | 9.33 |
| Earnings Yield | -38.37% |
| PEGY Ratio | -0.3487 |